TORNTPHARM an outlook changed

as of Wed 7 Oct 15:30

TORRENT PHARMACEUTICALS L filed an outlook changed of India Ratings and Research Private Limited IND AA+ on Wed 7 Oct 2026.

Its size: outlook only.

Where it came from

as of Wed 7 Oct 15:30
Sources
Filed
NSE · 2026-10-07 19:32 IST
Document
raw/nse_announcement_docs/2026-10-07/105645eba238_105645eba238_TORNTPHARM_07102026193222_SEIntimationIndiaRatings071026.pdf · SHA-256 105645eba238
Read from
“Affirmed the credit rating and revised the outlook from stable to positive of the Company’s existing banking facilities, issuer rating and Non-Convertible Debentures. The rating along with outlook is IND AA+/Positive” · page 1 · characters 1499–1717
Read by
claude-sonnet-5 · prompt 8c43350f344fef0c · 9 of 9 checks passed
Measured against
the steps of the rating scale · as of 6 Oct 2026
Kind
credit rating action

What such filings have been followed by

as of Wed 7 Oct 15:30
OverInBeyond its normal dayBeyond what options priced
This stockthe next session0 of 11 of 1
This stockthe next five sessions0 of 11 of 1
Its industry (Healthcare)the next session0 of 116 of 11
Its industry (Healthcare)the next five sessions0 of 113 of 11
Every stockthe next session16 of 12048 of 120
Every stockthe next five sessions8 of 11938 of 118

Counts of past filings of the same kind and size: of how many, how many were followed by a move bigger than the stock's own normal day, and bigger than what its options priced for the same span. A greyed row has fewer than 30 cases, too few to read as a tendency, and its counts are printed anyway. A filing whose sessions have not all arrived is not counted.